| Identification | Back Directory | [Name]
CDH | [CAS]
4682-48-8 | [Synonyms]
LC
CDH
LACCER
cytolipinh
LC, BOVINE
gangliosidega3
LACCER, BOVINE
gangliosidegl2a
Lactosylceramid
LACTOCEREBROSIDES
LACTOSYL CERAMIDE
GAL-BETA1,4GLC-CER
CERAMIDE DIHEXOSIDE
Ceramide β-lactoside
Ceramide-β-D-lactoside
CERAMIDE BETA-LACTOSIDE
GAL-BETA1,4GLC-CERAMIDE
lactocerebrosides bovine
LACTOSYL CERAMIDE, BOVINE
LACTOSYL CERAMIDE, PORCINE
LACTOSYL CERAMIDES, BOVINE
GAL-BETA,1,4GLC-CER, BOVINE
LACTOSYLCERAMIDE, FROM BOVINE
Lactosylceramide (d18:1/12:0)
Lactosylceramide (d18:1/16:0)
Lactosylceramide (d18:1/18:0)
Lactosylceramide (d18:1/20:0)
Lactosylceramide (d18:1/26:0)
Lactosylceramide (d18:1/22:0)
Lactosylceramide (d18:1/24:0)
Lactosylceramide (d18:1/25:0)
n-lignocerylsphingosyllactoside
Lactosylceramide (d18:1/9Z-18:1)
GAL-BETA1,4GLC-CERAMIDE, PORCINE
Lactosylceramide (d18:1/24:1(15Z))
Lactosylceramide (d18:1/26:1(17Z))
lactocerebrosides from bovine brain
Cerebronylsphingosylglucosidogalactoside
Lactosyl Ceramide, Bovine - CAS 4682-48-8 - Calbiochem
1-o-(4-o-beta-d-galactopyranosyl-beta-glucopyranosyl)ceramide
1-o-(4-o-beta-d-galactopyranosyl-beta-glucopyranosyl)-ceramid
CDH, Ceramide β-lactoside, Ceramide dihexoside, Ceramide-β-D-lactoside
6-[[7-(N,N-Dimethylaminosulfonyl)-2,1,3-benzoxadiazol-4-yl]amino]hexanoicAcid>
N-[(1S,2R,E)-1-[[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecenyl]tetracosanamide
N-[(E)-1-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-3-hydroxy-octadec-4-en-2-yl]octadecanamide
(2R,3S)-N-[[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3-[(E)-hexadec-3-enyl]-2-hydroxytetracosanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)icosanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)docosanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)hexacosanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)octadecanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)hexadecanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)tetracosanamide
N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)pentacosanamide
(Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)octadec-9-enamide
(Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)hexacos-17-enamide
(Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)tetracos-15-enamide | [Molecular Formula]
C53H101NO13 | [MDL Number]
MFCD00133445 | [MOL File]
4682-48-8.mol | [Molecular Weight]
960.37 |
| Chemical Properties | Back Directory | [Melting point ]
230-240° with sintering at 180-190° | [alpha ]
D24 -10.8° (c = 2 in pyridine) | [storage temp. ]
−20°C | [solubility ]
chloroform/methanol (9:1): 10 mg/mL, clear, faintly yellow | [form ]
Colorless solid | [color ]
White to off-white | [Merck ]
13,2823 | [InChIKey]
VOZHMDQUIRUFQW-AIRKALMMSA-N | [SMILES]
N(C(C(O)\C=C\CCCCCCCCCCCCC)CO[C@@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)OC2O[C@@H]([C@@H]([C@@H]([C@H]2O)O)O)CO)CO)C(=O)CCCCCCCCCCCCCCCCC |
| Hazard Information | Back Directory | [Uses]
Lactosylceramide is a sphingolipid that regulates apoptosis, proliferation and stress response. It also play a role in pathogenesis and progression of genetic and non-genetic forms of chronic kidney diseases. Lactosyceramide is also important for the functioning of many cellular processess. It is highly expressed on the plasma membrane of human neutrophils and mediates innate immune functions. | [Biological Activity]
Cell permeable: no''Primary Target
A neutral glycosphingolipid (GSL) th at is the common precursor of the ganglio-globo-globoiso-lacto-neolacto-and muco-series of GSL''Product does not compete with ATP.''Reversible: no |
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Website: |
https://www.alfa-chemistry.com |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
|